Elemental Recipe 113 - Advanced Endocrine Compounds
Publicly online since 2010 · U.S. patent applications since 2012 · inventions offered since 2014. The work of Christopher Gabriel Brown, independently documented.
Recipe 113 — Category F
Advanced Endocrine Compounds
Iodine-selenium thyroid regulators, chromium-vanadium insulin mimetics, molybdenum hormone modulators, and strontium bone-endocrine agents.
Key Elements
I, Se, Cr, V, Zn, Mo, Cu, Ge, Sr, Ca
Therapeutic Mechanisms
What You Receive
- Complete molecular formula with elemental composition table
- Mass percentages and purity requirements for each element
- Full synthesis parameters (temperature, pressure, catalyst, time, yield, solvent)
- Preparation notes and quality control specifications
- Therapeutic category classification and mechanism analysis
This recipe is part of a 300-compound patent-pending library covering 15 therapeutic categories.
| Product | Elemental Recipe 113 - Advanced Endocrine Compounds |
| Format | Recipe acquisition — formula, synthesis parameters, QC specifications |
| Subject | Computational recipe for a endocrine-balance support elemental compound — formula, synthesis parameters, and QC specifications for one-chemist productization. |
| Worked example | A endocrine-balance support blend built on this recipe's element list (Se, Cr, Zn, Mo, Cu, Ge, Sr, Ca) — structure/function support, not a cure. |
| Elements in this recipe | Se, Cr, Zn, Mo, Cu, Ge, Sr, Ca |
| IP posture | Patent Pending — produced by the Alchemy Data Three compound-mechanism substrate. |
| Author | Christopher Gabriel Brown · Lawrenceville, GA, USA |
| Price | $110,000 |
01 What is inside
- The full endocrine-balance support recipe — element list, target ratios, and synthesis parameters from the Alchemy Data substrate.
- Outreach template #1 — ready to send to a formulation chemist or compounding pharmacist.
- Outreach template #2 — ready to send to a 21 CFR Part 111 contract manufacturer.
- Ingredient sourcing checklist — USP/food-grade forms, target doses, and the Tolerable Upper Limit references.
- Allowed and disallowed claim language tailored to the Endocrine category.
- Hand-off documentation suitable for an NDA-gated formulation review.
02 The team — your “one chemist”
The whole trick is that you do not synthesize anything. Every ingredient already exists as a USP/food-grade raw material you simply buy. So the real job is formulate → source → have it made → label honestly, and that genuinely is a one-chemist operation:
- You — the formula concept and IP holder.
- One formulation chemist or compounding pharmacist (contract/consulting) — finalizes the formula, forms, and doses, and writes the spec. This is the single chemist.
- A 21 CFR Part 111 contract manufacturer — does the actual blending, encapsulation, and QC testing. They already have the bench chemists and lines, so you build nothing.
03 The six steps, formula to shelf
| 1 | The formulation chemist finalizes the formula, doses, and capsule form within safe upper limits. |
| 2 | Source COA'd (certificate-of-analysis) USP/food-grade raw materials from established suppliers. |
| 3 | File an NDI notification only if an ingredient is post-Oct-1994 or novel — standard chelates are not (any novel coordination complexes stay out of the supplement entirely; those are the drug road). |
| 4 | The Part 111 contract manufacturer blends, encapsulates, tests (identity, purity, heavy metals), and returns a batch record + COA. |
| 5 | Label per 21 CFR 101: Supplement Facts panel, structure/function claims only + the FDA disclaimer; notify the FDA within 30 days of first using a claim. |
| 6 | You hold safety responsibility and serious-adverse-event reporting. |
04 What you may — and may not — say
| Allowed (structure/function) | Not allowed (disease claims) |
| “Supports healthy endocrine function.” “A source of Selenium, Chromium, and Zinc for normal thyroid function.” “Supports the body's natural antioxidant defenses for endocrine glands.” | “Treats thyroid disease.” “Balances hormones medically.” “Cures adrenal fatigue.” “For Hashimoto's / Graves' / PCOS.” |
Required on every claim: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
05 Ingredients — buy them, do not make them
| Ingredient | Form to order | Target dose | Why |
|---|---|---|---|
| Selenium | L-selenomethionine | ≤200 mcg/day (below 400 mcg UL) | antioxidant defense (glutathione peroxidase) — for endocrine glands |
| Chromium | chromium picolinate or chromium nicotinate | ≤200 mcg/day | glucose-metabolism cofactor — for endocrine glands |
| Zinc | zinc bisglycinate (chelate) | ≤30 mg elemental/day (below 40 mg UL) | antioxidant defense; enzyme cofactor — for endocrine glands |
| Molybdenum | molybdenum glycinate | ≤2 mg/day (below 2 mg UL) | sulfite oxidase cofactor — for endocrine glands |
| Copper | copper bisglycinate | 2 mg/day | antioxidant and ferroxidase cofactor — for endocrine glands |
| Germanium | germanium-132 (bis-carboxyethyl germanium sesquioxide) | investigational — chemist guidance | research-tier element — for endocrine glands |
| Strontium | strontium citrate | ≤680 mg/day | skeletal matrix research support — for endocrine glands |
| Iron | EXCLUDED | — | pro-oxidant risk to endocrine tissue |
06 Who to hire (and where to find them)
- Nutraceutical formulation chemist or compounding pharmacist (503A) — via a contract-manufacturer's R&D team or a supplement-industry consultant. This is your single chemist.
- If you ever want the actual novel coordination complexes synthesized (the patent-pending compounds themselves rather than a standard chelate): a bioinorganic / coordination chemist. That is the drug road, not this supplement.
07 Copy-ready outreach
to a formulation chemist / compounding pharmacist
Subject: Formulation help — endocrine-balance support mineral / amino-acid supplement Hi [Name], I'm developing a dietary supplement (structure/function support — not a drug) built around Selenium, Chromium, Zinc, Molybdenum, Copper, with conservative dosing within Tolerable Upper Limits. I have the formula concept and the evidence basis (Alchemy Data Three substrate), and I'm looking for a formulation chemist or compounding pharmacist to: 1. finalize doses and forms within safe upper limits, 2. spec USP/food-grade raw materials and a Part-111 contract manufacturer, 3. keep it compliant — structure/function claims only, no disease claims. Small initial run to start. Could we set up a 20-minute scoping call? Thanks, Christopher Gabriel Brown · christopher@cri-one.com · cri-one.com
to a Part 111 contract manufacturer
Subject: Small-run nutraceutical — endocrine-balance support capsule, seeking a Part-111 partner Hi [Company] team, I'm bringing a dietary supplement to market — a capsule blend built on Selenium, Chromium, Zinc, Molybdenum, Copper at conservative doses (structure/function support; no disease claims). The formula concept is done; I'm looking for a 21 CFR Part 111 contract manufacturer to: 1. finish / validate the formulation, 2. source COA'd USP / food-grade raws, 3. run a small initial batch with full QC (identity, purity, heavy metals) + COA, 4. hand back Supplement-Facts-ready specs. Could you share your minimum order quantities, lead times, and per-unit pricing for a run like this? Happy to send the draft formula under NDA. Thanks, Christopher Gabriel Brown · christopher@cri-one.com · cri-one.com
Meaningful use direction
The most meaningful research direction for this recipe is the endocrine-research supplements supporting thyroid and adrenal cofactor pools without disease claims path. Anchored to this recipe's element list (Selenium, Chromium, Zinc, Molybdenum, Copper), the realistic productization is a capsule or tablet that supports thyroid and adrenal cofactor support, hormone-balance research markers, and endocrine antioxidant defense — framed entirely as computational research findings, not as a therapy for any specific condition.
Inquiries by email or postal mail only — no phone calls, no brokers, no intermediaries. USA buyers, USD only. christopher@cri-one.com · crioneaka@outlook.com · Christopher Gabriel Brown, 1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA.
Disclaimer. Computational research findings — not medical advice, not clinically tested, not FDA-approved. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Educational only. Not medical, legal, or regulatory advice; not affiliated with or endorsed by the FDA. Dietary-supplement rules (DSHEA, NDI, 21 CFR 101/111) change over time — confirm current requirements with the FDA, a qualified formulation chemist, and a supplement attorney before manufacturing or labeling anything.
